These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30552887)

  • 1. Cardio-omentopexy Reduces Cardiac Fibrosis and Heart Failure After Experimental Pressure Overload.
    Wang J; Zhang QJ; Pirolli TJ; Liu ZP; Powell L; Thorp EB; Jessen M; Forbess JM
    Ann Thorac Surg; 2019 May; 107(5):1448-1455. PubMed ID: 30552887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis.
    Weinberg EO; Schoen FJ; George D; Kagaya Y; Douglas PS; Litwin SE; Schunkert H; Benedict CR; Lorell BH
    Circulation; 1994 Sep; 90(3):1410-22. PubMed ID: 8087951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pressure-volume analysis reveals characteristic sex-related differences in cardiac function in a rat model of aortic banding-induced myocardial hypertrophy.
    Ruppert M; Korkmaz-Icöz S; Loganathan S; Jiang W; Lehmann L; Oláh A; Sayour AA; Barta BA; Merkely B; Karck M; Radovits T; Szabó G
    Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H502-H511. PubMed ID: 29799277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardio-omentopexy requires a cardioprotective innate immune response to promote myocardial angiogenesis in mice.
    Ge ZD; Boyd RM; Lantz C; Thorp EB; Forbess JM
    JTCVS Open; 2022 Jun; 10():222-242. PubMed ID: 36004249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure.
    Litwin SE; Katz SE; Weinberg EO; Lorell BH; Aurigemma GP; Douglas PS
    Circulation; 1995 May; 91(10):2642-54. PubMed ID: 7743628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular hypertrophy induced by abdominal aortic banding and its prevention by angiotensin receptor blocker telmisartan--a proteomic analysis.
    Liu L; Wang W; Meng X; Gao J; Wu H; Wang P; Wu W; Wang L; Ma L; Zhang W
    J Physiol Biochem; 2010 Dec; 66(4):329-38. PubMed ID: 20697985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial reverse remodeling after pressure unloading is associated with maintained cardiac mechanoenergetics in a rat model of left ventricular hypertrophy.
    Ruppert M; Korkmaz-Icöz S; Li S; Németh BT; Hegedűs P; Brlecic P; Mátyás C; Zorn M; Merkely B; Karck M; Radovits T; Szabó G
    Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H592-603. PubMed ID: 27342874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new model of congestive heart failure in rats.
    Chen J; Chemaly ER; Liang LF; LaRocca TJ; Yaniz-Galende E; Hajjar RJ
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H994-1003. PubMed ID: 21685270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
    Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
    Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload.
    Grieve DJ; Byrne JA; Siva A; Layland J; Johar S; Cave AC; Shah AM
    J Am Coll Cardiol; 2006 Feb; 47(4):817-26. PubMed ID: 16487851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periostin is a novel factor in cardiac remodeling after experimental and clinical unloading of the failing heart.
    Stansfield WE; Andersen NM; Tang RH; Selzman CH
    Ann Thorac Surg; 2009 Dec; 88(6):1916-21. PubMed ID: 19932262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in molecular remodeling in pressure overload hypertrophy.
    Weinberg EO; Thienelt CD; Katz SE; Bartunek J; Tajima M; Rohrbach S; Douglas PS; Lorell BH
    J Am Coll Cardiol; 1999 Jul; 34(1):264-73. PubMed ID: 10400020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Myocardial Stiffness in Patients With High-Risk Left Ventricular Hypertrophy: The Hallmark of Stage-B Heart Failure With Preserved Ejection Fraction.
    Hieda M; Sarma S; Hearon CM; Dias KA; Martinez J; Samels M; Everding B; Palmer D; Livingston S; Morris M; Howden E; Levine BD
    Circulation; 2020 Jan; 141(2):115-123. PubMed ID: 31865771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.
    Garcia AG; Wilson RM; Heo J; Murthy NR; Baid S; Ouchi N; Sam F
    Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H587-96. PubMed ID: 22730392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in cardiac structure and function in a modified rat model of myocardial hypertrophy.
    Dai W; Dong Q; Chen M; Zhao L; Chen A; Li Z; Liu S
    Cardiovasc J Afr; 2016; 27(3):134-142. PubMed ID: 27841899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of rosuvastatin on cardiac remodeling, function, and progression to heart failure in hypertensive heart with established left ventricular hypertrophy.
    Chang SA; Kim YJ; Lee HW; Kim DH; Kim HK; Chang HJ; Sohn DW; Oh BH; Park YB
    Hypertension; 2009 Sep; 54(3):591-7. PubMed ID: 19564547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myofilament Ca
    Ruppert M; Bódi B; Korkmaz-Icöz S; Loganathan S; Jiang W; Lehmann L; Oláh A; Barta BA; Sayour AA; Merkely B; Karck M; Papp Z; Szabó G; Radovits T
    J Mol Cell Cardiol; 2019 Apr; 129():208-218. PubMed ID: 30844361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure.
    Meguro T; Hong C; Asai K; Takagi G; McKinsey TA; Olson EN; Vatner SF
    Circ Res; 1999 Apr; 84(6):735-40. PubMed ID: 10189362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis.
    Weinberg EO; Lee MA; Weigner M; Lindpaintner K; Bishop SP; Benedict CR; Ho KK; Douglas PS; Chafizadeh E; Lorell BH
    Circulation; 1997 Mar; 95(6):1592-600. PubMed ID: 9118530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.